Interstitial lung disease before and after COVID-19: a double threat?
Claudia Valenzuela, Grant Waterer, Ganesh Raghu
Abstract
<b>Pre-existing ILD and pulmonary fibrosis increases the risk to manifest severe COVID-19. Residual interstitial lung changes and sequelae have been observed in COVID-19 survivors. A closer and standardised long-term follow-up of these patients is needed.</b>https://bit.ly/3jWBPCG
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Interstitial lung diseasePulmonary fibrosisLungSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakDiseaseIdiopathic pulmonary fibrosisLung diseaseFibrosisIntensive care medicineInternal medicinePathologyInfectious disease (medical specialty)OutbreakChronic Obstructive Pulmonary Disease (COPD) ResearchInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisLong-Term Effects of COVID-19